Subscribe to our monthly newsletter Subscribe

ClearRead XRay - Confirm

Riverain Technologies

ClearRead XRay identifies and highlights lines and tubes on portable chest X-ray images.

Information source: Vendor
Last updated: June 20, 2022

General Information

General
Product name	ClearRead XRay - Confirm
Company	Riverain Technologies
Subspeciality	Chest
Modality	X-ray
Disease targeted	Lung cancer
Key-features	Improved visibility of lines and tubes
Suggested use	During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion

Technical Specifications

Data characteristics
Population	Adult, not pediatric
Input	PA/AP chest view, showing both lungs
Input format	DICOM
Output	Enhanced image: enhanced visibility of line/tubes, suppression normal bone structures (ribs and clavicles)
Output format	DICOM Secondary Capture
Technology
Integration	Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform
Deployment	Locally on dedicated hardware, Locally virtualized (virtual machine, docker)
Trigger for analysis	Automatically, right after the image acquisition
Processing time	1 - 10 minutes

Regulatory

Certification
CE	Certified, Class IIa , MDR
FDA	510(k) cleared , Class II
Intended Use Statements
Intended use (according to CE)	ClearRead Xray \| Enhance/Confirm is intended to generate an enhanced, secondary digital radiographic image of the chest to facilitate detection of line/tubes. The enhanced AP or PA image of the chest provides improved visibility of lines and tubes. The Enhance/Confirm image provides adjunctive information and is not a substitute for the original PA/AP image. This device is intended to be used by trained professionals, such as physicians, radiologists, and technicians, on patients with lines and tubes and is not intended to be used on pediatric patients.

Market

Market presence
On market since	11-2012
Distribution channels	Sectra Amplifier Store, Aidoc aiOS, Volpara Health, GE Healthcare
Countries present (clinical, non-research use)	13
Paying clinical customers (institutes)	200+
Research/test users (institutes)	5
Pricing
Pricing model	Subscription, One-time license fee
Based on	Number of analyses

Evidence

Evidence
Peer reviewed papers on performance
Non-peer reviewed papers on performance
Other relevant papers